Alan Ezekowitz

Insider Reports History

Location
C/O Fulcrum Therapeutics, Inc., 26 Landsdowne Street, Cambridge, MA
Signature
/s/ Greg Tourangeau, as attorney-in-fact for Alan Ezekowitz
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Alan Ezekowitz:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Septerna, Inc. Director Common Stock 117K $813K $6.93 Mar 7, 2025 Direct
Organon & Co. Director Phantom Stock 62.7K $630K $10.04 Jun 13, 2025 Direct
Fulcrum Therapeutics, Inc. Director Stock Option (right to buy) 36K Jun 26, 2025 Direct
Septerna, Inc. Director Stock Option (Right to Buy) 16.6K Jun 17, 2025 Direct

Insider Reports Filed by Alan Ezekowitz

Symbol Company Period Transactions Value $ Form Type Date Filed Role
FULC Fulcrum Therapeutics, Inc. Jun 26, 2025 1 $0 4 Jun 30, 2025 Director
SEPN Septerna, Inc. Jun 17, 2025 1 $0 4 Jun 20, 2025 Director
OGN Organon & Co. Jun 13, 2025 1 $240K 4 Jun 16, 2025 Director
SEPN Septerna, Inc. Mar 7, 2025 1 $92.3K 4 Mar 10, 2025 Director
SEPN Septerna, Inc. Mar 4, 2025 3 $516K 4 Mar 6, 2025 Director
SEPN Septerna, Inc. Oct 24, 2024 0 $0 3 Oct 24, 2024 Director
FULC Fulcrum Therapeutics, Inc. Jun 17, 2024 1 $0 4 Jun 18, 2024 Director
OGN Organon & Co. Jun 7, 2024 1 $200K 4 Jun 11, 2024 Director
FULC Fulcrum Therapeutics, Inc. Jun 27, 2023 1 $0 4 Jun 29, 2023 Director
OGN Organon & Co. Jun 9, 2023 1 $200K 4 Jun 13, 2023 Director
FULC Fulcrum Therapeutics, Inc. Jun 27, 2022 2 $0 4 Jun 29, 2022 Director
OGN Organon & Co. Jun 10, 2022 1 $200K 4 Jun 14, 2022 Director
FULC Fulcrum Therapeutics, Inc. Jun 9, 2021 1 $0 4 Jun 11, 2021 Director
OGN Organon & Co. Jun 4, 2021 1 $316K 4 Jun 8, 2021 Director
OGN Organon & Co. Jun 2, 2021 0 $0 3 Jun 2, 2021 Director